Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.064 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |